Latest studies into retatruptide peptide reveal significant outlook for addressing weight and non-insulin dependent diabetes mellitus. The peptide, a dual stimulator of glucagon-like peptide-1 and GIP, appears to offer improved weight loss and glycemic regulation compared existing therapies. Ongo